TTR and familial amyloid neuropathy: Therapeutic modalities for ATTRv amyloidosis encompass a range of interventions, including transthyretin tetramer stabilizers such as Tafamidis, pharmacotherapies targeting transthyretin reduction like Patisiran, and surgical interventions such as liver transplantation (7, 8).